Showing results (141-150 of 12,106) with videos related to
Sort By:
Pageof 1,211
Neuropharmacology|February 16, 2016
Predictors of cognitive decline and treatment response in a clinical trial on suspected prodromal Alzheimer's diseaseStefan J Teipel, Enrica Cavedo, Michel J Grothe, et al.Neuropharmacology|November 1, 1989
Ventral tegmental area-mediated inhibition of neurons of the nucleus accumbens receiving input from the parafascicular nucleus of the thalamus is mediated by dopamine D1 receptorsM Hara, M Sasa, S TakaoriNeuropharmacology|February 25, 2016
Naturally occurring autoantibodies against Aβ oligomers exhibited more beneficial effects in the treatment of mouse model of Alzheimer's disease than intravenous immunoglobulinTeng Wang, Xi-Xiu Xie, Mei Ji, et al.Neuropharmacology|April 10, 2016
Lysophosphatidic acid receptors (LPARs): Potential targets for the treatment of neuropathic painMaría Velasco, Catherine O'Sullivan, Graham K SheridanNeuropharmacology|April 9, 2016
Muscarinic acetylcholine receptor-mediated stimulation of retinal ganglion cell photoreceptorsPuneet Sodhi, Andrew T E HartwickNeuropharmacology|April 9, 2016
Metabotropic glutamate receptors as therapeutic targets in Parkinson's disease: An update from the last 5 years of researchNadhir Litim, Marc Morissette, Thérèse Di PaoloNeuropharmacology|April 13, 2016
Morin reverses neuropathological and cognitive impairments in APPswe/PS1dE9 mice by targeting multiple pathogenic mechanismsYing Du, Jie Qu, Wei Zhang, et al.Neuropharmacology|April 10, 2016
Integrated regulation of AMPA glutamate receptor phosphorylation in the striatum by dopamine and acetylcholineBing Xue, Elton C Chen, Nan He, et al.Neuropharmacology|November 5, 2016
CB1 cannabinoid receptor-mediated anandamide signalling reduces the defensive behaviour evoked through GABAA receptor blockade in the dorsomedial division of the ventromedial hypothalamusTayllon Dos Anjos-Garcia, Farhad Ullah, Luiz Luciano Falconi-Sobrinho, et al.Neuropharmacology|March 17, 2016
The need for new approaches in CNS drug discovery: Why drugs have failed, and what can be done to improve outcomesValentin K Gribkoff, Leonard K KaczmarekPageof 1,211